Indications
  • Uncontrolled moderate-to-severe atopic dermatitis for patients ages 6+
  • Moderate-to-severe asthma with an eosinophilic phenotype or oral corticosteroid dependent asthma for patients ages 12+
    Limitation of Use: not for relief of acute bronchospasm or status asthmaticus
  • Inadequately controlled chronic rhinosinusitis with nasal polyposis for patients 18+